Tvardi Therapeutics, Inc.
TVRD
$27.97
$1.324.95%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | 4.17M | -9.58M | -12.71M | -6.98M | |
| Total Depreciation and Amortization | 23.00K | 24.00K | 24.00K | 23.00K | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -12.08M | 5.53M | 2.07M | 94.00K | |
| Change in Net Operating Assets | 2.03M | -3.66M | 5.78M | 4.18M | |
| Cash from Operations | -5.87M | -7.69M | -4.83M | -2.68M | |
| Capital Expenditure | -- | -- | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -9.55M | -10.88M | -- | -- | |
| Cash from Investing | -9.55M | -10.88M | -- | -- | |
| Total Debt Issued | -- | -- | 28.30M | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 421.00K | 3.00K | 0.00 | 0.00 | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | 24.21M | -1.61M | -1.29M | -- | |
| Cash from Financing | 24.63M | -1.60M | 27.01M | 0.00 | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 9.21M | -20.18M | 22.18M | -2.68M | |